Elevated serum ELABELA and SERPINA3 as novel biomarkers to predict poor prognosis in Egyptian chroni...
Elevated serum ELABELA and SERPINA3 as novel biomarkers to predict poor prognosis in Egyptian chronic lymphocytic leukemia patients
About this item
Full title
Author / Creator
Publisher
India: Wolters Kluwer - Medknow
Journal title
Language
English
Formats
Publication information
Publisher
India: Wolters Kluwer - Medknow
Subjects
More information
Scope and Contents
Contents
Abstract
Background
Chronic lymphocytic leukemia (CLL) is the most common kind of adult leukemia worldwide. Increased expressions of serpin peptidase inhibitor, clade A member 3 (SERPINA3) and apelin receptor early endogenous ligand (ELABELA) have been observed in various malignancies. However, there is little information on their clinical im...
Alternative Titles
Full title
Elevated serum ELABELA and SERPINA3 as novel biomarkers to predict poor prognosis in Egyptian chronic lymphocytic leukemia patients
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A768463200
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A768463200
Other Identifiers
ISSN
1110-1067
DOI
10.4103/ejh.ejh_2_23
